iclusig
incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. zobacz rozdziały 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.
duexon pro (50 mcg + 100 mcg)/dawkę proszek do inhalacji, podzielony
adamed pharma s.a. - salmeterolum + fluticasoni propionas - proszek do inhalacji, podzielony - (50 mcg + 100 mcg)/dawkę
letrox 75 mikrogramów 75 mcg tabletki
berlin-chemie ag - levothyroxinum natricum - tabletki - 75 mcg
letrox 125 mikrogramów 125 mcg tabletki
berlin-chemie ag - levothyroxinum natricum - tabletki - 125 mcg
clobex 500 mcg/g szampon leczniczy
galderma polska sp. z o.o. - clobetasoli propionas - szampon leczniczy - 500 mcg/g
otriallergy control 50 mcg/dawkę aerozol do nosa, zawiesina
haleon poland sp. z o.o. - fluticasoni propionas - aerozol do nosa, zawiesina - 50 mcg/dawkę
flutixon neb 0,5 mg/2 ml zawiesina do nebulizacji
adamed pharma s.a. - fluticasoni propionas - zawiesina do nebulizacji - 0,5 mg/2 ml
flutixon neb 2 mg/2 ml zawiesina do nebulizacji
adamed pharma s.a. - fluticasoni propionas - zawiesina do nebulizacji - 2 mg/2 ml
veriflo (25 mcg + 250 mcg)/dawkę inh. aerozol inhalacyjny, zawiesina
zentiva, k.s. - salmeterolum + fluticasoni propionas - aerozol inhalacyjny, zawiesina - (25 mcg + 250 mcg)/dawkę inh.
veriflo (25 mcg + 125 mcg)/dawkę inh. aerozol inhalacyjny, zawiesina
zentiva, k.s. - salmeterolum + fluticasoni propionas - aerozol inhalacyjny, zawiesina - (25 mcg + 125 mcg)/dawkę inh.